Patents Examined by Lester I. Lee
  • Dialysates for treating aids and arc and for otherwise increasing immune response
    Patent number: 5093321
    Abstract: Purified human leukocyte dialysates are described for treatment of AIDS, ARC, and other immunodeficient conditions. The dialysates are purified by HPLC processes, and are made available in a form that is free of endotoxin and pyrogen. A dialysate designated Beta-1.11 is found by amino acid sequencing to consist essentially of endogenous Tyr-Gly. A dialysate designated Beta-1.12 is found by amino acid sequencing to consist essentially of endogenous Tyr-Gly-Gly.
    Type: Grant
    Filed: January 24, 1990
    Date of Patent: March 3, 1992
    Assignee: Imreg, Inc.
    Inventor: A. A. Gottlieb